Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Journals

  Journals

Clinical Epigenetics

Clinical Epigenetics
More information
Current Biology

Current Biology
More information
Developmental Biology

Developmental Biology
More information
Drug Discovery Today

Drug Discovery Today
More information
Gene

Gene
More information
Genes & Development

Genes & Development
More information
Genome Research

Genome Research
More information
Genomics, Proteomics and Bioinformatics

Genomics, Proteomics and Bioinformatics
More information
Journal of RNAi and Gene Silencing

Journal of RNAi and Gene Silencing
More information
<< 1 2 3 >>
showing results 10 to 18 of 27
Scientific News
Promise for Treatment of Pancreatic Cancer
Ultrasound microbubbles can improve tumor absorption of cancer drugs.
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.
What Lies Behind the Death of Stem Cells
Researchers have identified key processes that control stem cell survival, providing insights that could improve their use in medicine.
Genetic Testing for Prostate Cancer
Genetic testing can identify men at six-fold increased risk of prostate cancer.
Redefining High Risk Patients With Stage II Colon Cancer
microRNA-21 identified as an independent prognostic biomarker.
Leukemia Subtype Becomes More Common With Age
Genomic Analysis of 1,725 patients reveals the prevalence of Ph-like ALL increases with age.
Ovarian Cancer Oncogene Found in "Junk DNA"
The study is published online in this week in Cancer Cell.
New Genetic Target for a Different Kind of Cancer Drug
Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that is drastically reduced in human lung and breast cancer cells.
Combination microRNA Therapy Suppresses Non-Small-Cell Lung Cancer
Findings offer a promising therapeutic avenue for NSCLC.
Breakthrough Melanoma Treatment, Keytruda, Developed
New immunotherapy launched in the US for treatment of adults with advanced melanoma, developed using antibody humanization expertise at UK’s MRC Technology.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv